Table 1 Baseline demographics and advanced heart-failure therapies
CCMP n (%) | NICMP n (%) | ICMP n (%) | p Value (All groups) | p Value CCMP vs NICMP | p Value CCMP vs All other | |
|---|---|---|---|---|---|---|
19 (3.4) | 225 (40.7) | 309 (55.9) | ||||
Age, (yrs) Mean (SD) | 57.8 ± 12.4 | 50.1 ± 13.9 | 61.1 ± 9.7 | < 0.0001 | 0.0196 | ns |
Male n (%) | 6 (31.6) | 156 (69.3) | 262 (84.8) | < 0.0001 | 0.0008 | < 0.0001 |
White n (%) | 9 (47.4) | 76 (33.8) | 153 (49.5) | 0.0012 | ns | ns |
Black n (%) | 6 (31.6) | 101 (44.9) | 67 (19.7) | < 0.0001 | ns | ns |
Hispanic n (%) | 4 (21) | 34 (15.1) | 46 (14.9) | ns | ns | ns |
Total LVAD n (%) | 5 (26.3) | 33 (14.7) | 79 (25.6) | 0.0013 | ns | ns |
DT | 3 (15.8) | 23 (10.2) | 61 (19.7) | 0.0029 | ns | ns |
BTT | 2 (10.5) | 10 (4.4) | 18 (5.8) | ns | ns | ns |
Total OHT n (%) | 5 (26.3) | 45 (20) | 43 (13.9) | ns | ns | ns |
OHT only | 3 (15.8) | 35 (15.5) | 25 (8.1) | 0.0150 | ns | ns |
OHT, VAD or Both n (%) | 8 (42.1) | 68 (30.2) | 104 (33.6) | ns | ns | ns |
Medical therapy n (%) | 11 (57.9) | 157 (69.8) | 205 (66.3) | 0.0388 | ns | ns |